Covalent-Allosteric Kinase Inhibitors-Reference-Cited by-同舟云学术

Covalent-Allosteric Kinase Inhibitors

Published:2015-06-25 Issue:35 Volume:54 Page:10313-10316
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Weisner Jörn,Gontla Rajesh,van der Westhuizen Leandi,Oeck Sebastian,Ketzer Julia,Janning Petra,Richters André,Mühlenberg Thomas,Fang Zhizhou,Taher Abu,Jendrossek Verena,Pelly Stephen C.,Bauer Sebastian,van Otterlo Willem A. L.,Rauh Daniel

Funder

German Federal Ministry for Education and Research

Deutsche Forschungsgemeinschaft (DFG)

Publisher

Wiley

Subject

General Chemistry,Catalysis

Reference30 articles.

1. Kinase Drug Discovery – What’s Next in the Field?

2. Advances in kinase targeting: current clinical use and clinical trials

3. Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis

4. Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural investigation of Trypanosoma cruzi Akt-like kinase as drug target against Chagas disease;Scientific Reports;2024-05-02

2. Redox Regulation of Brain Selective Kinases BRSK1/2: Implications for Dynamic Control of the Eukaryotic AMPK family through Cys-based mechanisms;2024-05-02

3. Redox Regulation of Brain Selective Kinases BRSK1/2: Implications for Dynamic Control of the Eukaryotic AMPK family through Cys-based mechanisms;2024-05-02

4. Redox Regulation of Brain Selective Kinases BRSK1/2: Implications for Dynamic Control of the Eukaryotic AMPK family through Cys-based mechanisms;2024-04-19

5. Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises;Journal of Medicinal Chemistry;2024-04-09